Concepedia

Mark M. Fuster

MM

Statistics

Publications

33

Citations

2.3K

H-Index

22

Active since

2001

Affiliations

University of California San Diego(Current)

VA San Diego Healthcare System

University of California System

Jiangsu Ocean University

Kaiser Permanente

Mark M. Fuster is an author at University of California San Diego specializing in oncology, life sciences, and medicine.

ORCID

Publications per year

2001–2022

33

Publications

33

Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses

Lianchun Wang, Mark M. Fuster, P. Sriramarao et al. · Nature Immunology · 2005 · 474 citations

, , +16

Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions

So Young Kim, Weihua Jin, Amika Sood et al. · Antiviral Research · 2020 · 325 citations · Full text

, , +11

Surfen, a small molecule antagonist of heparan sulfate

Manuela Schuksz, Mark M. Fuster, Jillian R. Brown et al. · Proceedings of the National Academy of Sciences · 2008 · 183 citations · Full text

, , +14

Tumor attenuation by combined heparan sulfate and polyamine depletion

Mattias Belting, Lubor Borsig, Mark M. Fuster et al. · Proceedings of the National Academy of Sciences · 2001 · 119 citations · Full text

, , +14

Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis

Mark M. Fuster, Lianchun Wang, Janice Castagnola et al. · The Journal of Cell Biology · 2007 · 113 citations · Full text

, , +15

1–5 of 33